Medicare Enrolled
Dr. Ravi Kamepalli, M.D.
Infectious Disease · Lagrange, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kamepalli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kamepalli?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kamepalli
Dr. Ravi Kamepalli is an infectious disease specialist in Lagrange, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kamepalli performed 4,751 Medicare services across 1,030 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kamepalli received a total of $2,480 from 42 pharmaceutical and/or device companies across 102 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kamepalli is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 11% volume in GA
$2,480 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,751
Medicare services
Top 11% in GA for infectious disease
1,030
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~238 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
2,682 | $59 | $100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
291 | $127 | $282 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
272 | $89 | $142 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
211 | $90 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
181 | $63 | $100 |
| Additional bone removal, per 20 sq cm This code covers the removal of bone tissue in increments of 20 square centimeters or less, billed for each additional area treated beyond the initial procedure. |
152 | $74 | $250 |
| Skin and tissue removal, 20 sq cm or less This procedure involves the surgical excision of skin and underlying tissue from an area measuring 20 square centimeters or smaller. |
148 | $83 | $150 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
146 | $28 | $80 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
129 | $78 | $160 |
| Additional tissue removal, per 20 sq cm This code covers the removal of extra muscle or tissue in increments of 20 square centimeters or less. It is used to bill for additional areas treated beyond the initial procedure. |
102 | $42 | $200 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
90 | $34 | $100 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
55 | $24 | $30 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
45 | $34 | $200 |
| Muscle or tissue removal, 20 sq cm or less This procedure involves the surgical removal of muscle or other tissue from the body. The total area of the removed tissue is 20.0 square centimeters or less. |
44 | $112 | $414 |
| Bone removal, 20 sq cm or less Surgical removal of a small area of bone, measuring 20 square centimeters or less. |
41 | $167 | $544 |
| Additional skin and tissue removal, per 20 sq cm This code covers the removal of skin and tissue for each additional 20 square centimeters or less beyond the initial procedure. |
39 | $19 | $80 |
| Therapy procedure using a special bandage and vacuum pump, surface area more than 50.0 sq cm | 29 | $20 | $100 |
| Vacuum-assisted wound closure therapy, 50 sq cm or less A therapy using a special bandage and vacuum pump to treat a wound surface area of 50.0 square centimeters or less. |
22 | $19 | $60 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $98 | $250 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
19 | $138 | $282 |
| New patient office visit, complex (60-74 min) | 16 | $134 | $314 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
15 | $123 | $216 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$2,480
Total received (2018-2024)
Avg $354/year across 7 years
Top 42% in GA for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
102
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,313 (93.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$167 (6.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$243
2023
$615
2022
$278
2021
$88
2020
$291
2019
$307
2018
$659
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Reprise Biomedical, Inc.
$104
Merck Sharp & Dohme LLC
$84
Amgen Inc.
$21
Aroa Biosurgery Incorporated
$18
Ferring Pharmaceuticals Inc.
$16
Top 3 companies account for 85.8% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme LLC
$285
Merck Sharp & Dohme Corporation
$201
AstraZeneca Pharmaceuticals LP
$169
Astellas Pharma US Inc
$145
Jazz Pharmaceuticals Inc.
$125
Boehringer Ingelheim Pharmaceuticals, Inc.
$125
Smith+Nephew, Inc.
$125
Ascensia Diabetes Care Us Inc.
$112
Reprise Biomedical, Inc.
$104
Ferring Pharmaceuticals Inc.
$95
Horizon Therapeutics plc
$87
Kerecis Limited
$76
Zealand Pharma US, Inc.
$65
Abbott Laboratories
$52
Amgen Inc.
$50
Gilead Sciences, Inc.
$49
Novo Nordisk Inc
$45
Janssen Biotech, Inc.
$42
Corcept Therapeutics
$41
CSL Behring
$37
Imbed Biosciences Inc.
$37
AbbVie, Inc.
$34
La Jolla Pharmaceutical Company
$31
Melinta Therapeutics, Inc.
$27
Medtronic, Inc.
$27
Medline Industries, Inc.
$24
Theravance Biopharma, Inc.
$24
Melinta Therapeutics, LLC
$23
CVRx, Inc.
$22
Lilly USA, LLC
$22
ViiV Healthcare Company
$21
Aroa Biosurgery Incorporated
$18
RedDress USA, Inc.
$18
Organogenesis Inc.
$17
Shire North American Group Inc
$16
Allergan, Inc.
$15
Allergan Inc.
$13
Electromed, Inc.
$13
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$12
Xeris Pharmaceuticals, Inc.
$12
DEXCOM, INC.
$12
ConvaTec Inc.
$11
Top 3 companies account for 26.4% of all-time payments
Associated products mentioned in payments ›
AQUACEL Ag Advantage · AVYCAZ · Apligraf · Barostim Neo System · Baxdela · CRESEMBA · CUVITRU · DEXCOM G6 TRANSMITTER · DIFICID · EVENITY · FARXIGA · FreeStyle Libre Pro · GRAFIX PL · GVOKE PFS · Hizentra · ISENTRESS · JANUVIA · JARDIANCE · JULUCA · KRYSTEXXA · Kerecis Omega3 SurgiClose · Kimyrsa · Korlym · LifeVest · Mavyret · Miro3D · PICO 7 · PIFELTRO · PREZCOBIX · REBYOTA · RENASYS GO v2 HOME · SMARTVEST · Santyl · Saxenda · TEFLARO · V-GO DISPOSABLE INSULIN DELIVERY · VENASEAL · VERQUVO · VIBATIV · XERAVA · Xyrem · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Infectious diseases within 10 mi
2
Per 100K population
2.9
County median income
$54,905
Nearest hospital
WELLSTAR WEST GEORGIA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kamepalli is a mixed practice specialist, with above-average Medicare volume (top 11% in GA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kamepalli experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Kamepalli performed 2,682 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kamepalli receive payments from pharmaceutical companies?
Yes. Dr. Kamepalli received a total of $2,480 from 42 companies across 102 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kamepalli's costs compare to other infectious diseases in Lagrange?
Dr. Kamepalli's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kamepalli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Infectious Diseases in Lagrange
Browse infectious diseases in Lagrange ranked by procedure volume and transparency data.
Highest volume
Top Infectious Diseases in GA
Infectious diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Infectious Diseases in GA
Which GA infectious diseases receive the most from drug and device companies.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology